1162900006: Product containing only amivantamab in parenteral dose form (medicinal product form)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Virtual therapeutic moiety\Amivantamab\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing amivantamab (medicinal product)\Product containing amivantamab in parenteral dose form (medicinal product form)\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing amivantamab (medicinal product)\Amivantamab\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing amivantamab (medicinal product)\Product containing amivantamab in parenteral dose form (medicinal product form)\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing amivantamab (medicinal product)\Amivantamab\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing amivantamab (medicinal product)\Product containing amivantamab in parenteral dose form (medicinal product form)\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing amivantamab (medicinal product)\Amivantamab\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing amivantamab (medicinal product)\Product containing amivantamab in parenteral dose form (medicinal product form)\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing amivantamab (medicinal product)\Amivantamab\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing amivantamab (medicinal product)\Product containing amivantamab in parenteral dose form (medicinal product form)\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing amivantamab (medicinal product)\Amivantamab\Product containing only amivantamab in parenteral dose form (medicinal product form)
• \Medicinal product\Product manufactured as parenteral dose form\Product containing amivantamab in parenteral dose form (medicinal product form)\Product containing only amivantamab in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4592033010	Product containing only amivantamab in parenteral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
4592034016	Amivantamab only product in parenteral dose form	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module

Expanded Value Set

This concept is not in any reference sets

Back to Start